DE60113689D1 - 2-aminothiazolinderivate und ihre verwendung als no-synthase inhibitoren - Google Patents

2-aminothiazolinderivate und ihre verwendung als no-synthase inhibitoren

Info

Publication number
DE60113689D1
DE60113689D1 DE60113689T DE60113689T DE60113689D1 DE 60113689 D1 DE60113689 D1 DE 60113689D1 DE 60113689 T DE60113689 T DE 60113689T DE 60113689 T DE60113689 T DE 60113689T DE 60113689 D1 DE60113689 D1 DE 60113689D1
Authority
DE
Germany
Prior art keywords
synthase inhibitors
aminothiazoline
derivatives
aminothiazoline derivatives
synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113689T
Other languages
English (en)
Other versions
DE60113689T2 (de
Inventor
Jean-Christophe Carry
Dominique Damour
Claude Guyon
Serge Mignani
Antony Bigot
Eric Bacque
Michel Tabart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60113689D1 publication Critical patent/DE60113689D1/de
Publication of DE60113689T2 publication Critical patent/DE60113689T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE60113689T 2000-06-09 2001-06-07 2-aminothiazolinderivate und ihre verwendung als no-synthase inhibitoren Expired - Lifetime DE60113689T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0007397A FR2810037B1 (fr) 2000-06-09 2000-06-09 Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible
FR0007397 2000-06-09
PCT/FR2001/001760 WO2001094325A1 (fr) 2000-06-09 2001-06-07 Derives de 2-aminothiazoline et leur utilisation comme inhibiteurs de no-synthase

Publications (2)

Publication Number Publication Date
DE60113689D1 true DE60113689D1 (de) 2006-02-09
DE60113689T2 DE60113689T2 (de) 2006-07-13

Family

ID=8851134

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113689T Expired - Lifetime DE60113689T2 (de) 2000-06-09 2001-06-07 2-aminothiazolinderivate und ihre verwendung als no-synthase inhibitoren

Country Status (29)

Country Link
EP (1) EP1299365B1 (de)
JP (1) JP4238026B2 (de)
KR (1) KR20030025931A (de)
CN (1) CN1202096C (de)
AP (1) AP2002002708A0 (de)
AR (1) AR029937A1 (de)
AT (1) ATE305460T1 (de)
AU (1) AU2001266124A1 (de)
BR (1) BR0111986A (de)
CA (1) CA2411760C (de)
DE (1) DE60113689T2 (de)
DK (1) DK1299365T3 (de)
DZ (1) DZ3367A1 (de)
EA (1) EA200300010A1 (de)
EC (1) ECSP024375A (de)
ES (1) ES2248347T3 (de)
FR (1) FR2810037B1 (de)
HK (1) HK1057900A1 (de)
HR (1) HRP20020970A2 (de)
HU (1) HUP0301000A2 (de)
IL (1) IL153328A0 (de)
MA (1) MA25814A1 (de)
MX (1) MXPA02012071A (de)
NO (1) NO20025884L (de)
NZ (1) NZ522968A (de)
OA (1) OA12286A (de)
PL (1) PL360285A1 (de)
WO (1) WO2001094325A1 (de)
ZA (1) ZA200209769B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461801A1 (en) * 2001-09-26 2003-04-03 Yissum Research Development Company Of The Hebrew University Of Jerusale M Sphingolipids
JP2005526005A (ja) * 2001-11-09 2005-09-02 アベンティス・ファーマ・ソシエテ・アノニム 誘導型ｎｏシンターゼの阻害剤としての２−アミノ−チアゾリン誘導体及びその使用
PL370267A1 (en) * 2001-11-09 2005-05-16 Aventis Pharma S.A. Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
MXPA04003766A (es) * 2001-11-09 2004-07-29 Aventis Pharma Sa Derivados de 2-amino-4-heteroariletil tiazolina y su utilizacion como inhibidores de no sintasa inducible.
AU2002238889A1 (en) * 2002-03-14 2003-09-22 Dainippon Pharmaceutical Co., Ltd. Nitrogen monoxide synthase inhibitors
ES2295672T3 (es) * 2002-08-07 2008-04-16 Neuraxon Inc. Compuestos de aminobenzotiazol con actividad inhibitoria de la oxido nitrico sintasa (nos).
DE10332560B4 (de) * 2003-07-11 2010-07-08 Chiracon Gmbh Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen
KR101800507B1 (ko) 2015-09-18 2018-01-18 주식회사 이엔이티아이 자동세척 스크린과 식물정화장치를 활용하여 지속적으로 유입되는 생활하수나 공정폐수가 유입되는 오염하천정화를 위한 방법 및 그 장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
AU5533094A (en) * 1992-11-27 1994-06-22 Wellcome Foundation Limited, The Enzyme inhibitors
EP0724570B1 (de) * 1993-10-21 1999-03-03 G.D. Searle & Co. Amidino-derivate als no-synthetase inhibitoren
AU4149696A (en) * 1994-11-15 1996-06-06 Merck & Co., Inc. Substituted heterocycles as inhibitors of nitric oxide synthase
AU2223501A (en) * 1999-12-24 2001-07-09 Kyowa Hakko Kogyo Co. Ltd. Fused purine derivatives

Also Published As

Publication number Publication date
ECSP024375A (es) 2003-02-06
DZ3367A1 (fr) 2001-12-13
NZ522968A (en) 2005-07-29
ATE305460T1 (de) 2005-10-15
MXPA02012071A (es) 2004-09-10
DE60113689T2 (de) 2006-07-13
HUP0301000A2 (hu) 2003-08-28
ES2248347T3 (es) 2006-03-16
JP2003535853A (ja) 2003-12-02
NO20025884D0 (no) 2002-12-06
NO20025884L (no) 2003-01-29
AU2001266124A1 (en) 2001-12-17
BR0111986A (pt) 2003-04-01
KR20030025931A (ko) 2003-03-29
EP1299365B1 (de) 2005-09-28
AP2002002708A0 (en) 2002-12-31
DK1299365T3 (da) 2006-02-06
HRP20020970A2 (en) 2005-02-28
MA25814A1 (fr) 2003-07-01
WO2001094325A1 (fr) 2001-12-13
JP4238026B2 (ja) 2009-03-11
FR2810037A1 (fr) 2001-12-14
CN1444572A (zh) 2003-09-24
OA12286A (en) 2006-05-12
PL360285A1 (en) 2004-09-06
CN1202096C (zh) 2005-05-18
AR029937A1 (es) 2003-07-23
HK1057900A1 (en) 2004-04-23
CA2411760A1 (fr) 2001-12-13
CA2411760C (fr) 2009-12-29
FR2810037B1 (fr) 2004-04-23
IL153328A0 (en) 2003-07-06
EP1299365A1 (de) 2003-04-09
ZA200209769B (en) 2004-03-02
EA200300010A1 (ru) 2003-06-26

Similar Documents

Publication Publication Date Title
DE60133897D1 (de) Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
DE60123210D1 (de) Picolinsäure-derivate und ihre verwendung als fungizide
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE344246T1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
ATE269701T1 (de) Gyrase-inhibitoren und ihre verwendung
DE60139477D1 (de) 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel
EE200300459A (et) Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
ATE280163T1 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
ATA5422000A (de) Oximderivate und ihre verwendung als latente säuren
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
DE60234167D1 (de) Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren
DE60113283D1 (de) Thiadiazole und oxadiazole sowie ihre verwendung als phosphodiesterase-7 inhibitoren
DE60118155D1 (de) 3-phenoxy-1-phenyl acetylenderivate und ihre verwendung als herbizide
DE60123461D1 (de) Salze eines 4-isothiazolcarboxamids und ihre verwendung als anti-hyperproliferationsmittel
DE60112635D1 (de) Ölzusammensetzung und ihre Verwendung
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
DE50313157D1 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
DE60102151D1 (de) Neue thiochromanderivate und ihre verwendung als thrombininhibitoren
ATE316087T1 (de) Isothiazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC